Flow Traders U.S.’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Flow Traders U.S.'s VRTX Position: Q2 2026 in Review
Flow Traders U.S. opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1,371 shares worth $681K. The stake represents 0.03% of the portfolio and ranks #540 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in VRTX as recently as Q4 2025.
Flow Traders U.S. first reported a position in VRTX in Q4 2024 and has held it in 3 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Flow Traders U.S. held 1,371 shares of Vertex Pharmaceuticals worth $681K as of Q2 2026.
- Vertex Pharmaceuticals was a new Flow Traders U.S. position in Q2 2026.
- Vertex Pharmaceuticals made up 0.03% of Flow Traders U.S.'s portfolio in Q2 2026, its #540 holding.
- Flow Traders U.S. first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.